North America is projected to be the fastest-growing High Performance Pharmaceutical Robots Market

Benefits offered by robotic systems in pharmaceutical manufacturing is a key factor driving the growth of pharmaceutical robots market. The base year considered for the study is 2015, and the forecast has been provided for the period between 2016 and 2021.

Robotic systems provide various benefits to pharmaceutical manufacturing such as lesser space utilization, reduced production downtime, no labor turnover, enhanced health and safety, better waste management, increased production flexibility, improved production output and product quality, and lower operating costs.

According to the new market research report by MarketsandMarkets, The overall pharmaceutical robotic systems market is expected to grow from USD 64.37 million in 2016 to USD 119.46 million by 2021, at a CAGR of 13.2% from 2016 to 2021.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=210985096

A robotic system is a type of automation that has multiple axes of motion and can be programmed to perform a function. Some of the benefits of automation include efficiency, saving workers from hazardous environments or repetitive tasks, reducing training overhead, eliminating human error, increasing repeatability and reproducibility, and in cleanrooms, removing the potential for human contamination.

On the basis of application, the global pharmaceutical robotic systems market is segmented into picking and packaging, inspection of pharmaceutical drugs, and laboratory applications. The picking and packaging segment accounted for the largest share of the global pharmaceutical robotic systems market.

Factors such as demand for personalized packaging configurations and advantages of robots in pharmaceutical manufacturing such as high speed, accuracy, ability to track and trace, error-free operation, fewer accidents, and better utilization of the floor space are contributing to the large share of the picking and packaging segment.

APAC accounted for the largest share of the APAC.

The pharmaceutical robotic systems market in APAC is expected to grow at the highest CAGR during the forecast period owing to factors such as the increase in domestic industrial robots companies, flourishing pharmaceutical industry, increasing number of conferences and exhibitions, investments and funding in the industrial robots industry, and Japan’s Robot Strategy.

Request for Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=210985096

Market Dynamics

Drivers

• Benefits offered by robotic systems in pharmaceutical manufacturing

• Conferences and exhibitions to raise awareness of robotic systems in pharmaceutical manufacturing

Restraints

• Lack of skilled personnel to work in automated manufacturing units

Opportunities

• Increased demand for collaborative robots in manufacturing facilities

Challenges

• Manufacturing advanced robotic systems that meet the requirements of consumers in the era of Industrial Internet of Things (IIoT)

Key Market Players :

Key players in the Pharmaceutical Robots Market include Kawasaki Heavy Industries Ltd. (Japan), FANUC Corporation (Japan), KUKA AG (Germany), Mitsubishi Electric Corporation (Japan), ABB Ltd. (Switzerland), Denso Corporation (Japan), Seiko Epson Corporation (Japan), Marchesini Group S.p.A (Italy), Universal Robots A/S (Denmark), Yaskawa Electric Corporation (Japan), and Shibuya Corporation (Japan).